FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval – Endpoints News July 6, 2022July 6, 2022
FDA sidelines Paul Hudson’s $3.7B MS drug after establishing link to liver damage – Endpoints News June 30, 2022June 30, 2022
Some pharma companies promise to cover abortion-related travel costs — while others won’t go that far yet – Endpoints News June 28, 2022June 28, 2022
That big R&D PARP win Clovis CEO Mahaffy touted a few weeks ago? The FDA isn’t buying it – Endpoints News May 7, 2022
Novo Nordisk’s blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss – Endpoints News February 11, 2021February 11, 2021